Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

JAK inhibitors might help treat alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ritlecitinib works well and is safe for treating alopecia areata.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Bimekizumab effectively treated a man's chronic beard hair loss.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

An arthritis drug helped a person with severe hair loss regrow their hair.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

BMS-470539 reduces skin fibrosis and inflammation.